Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease-Reference-Cited by-同舟云学术

Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease

Published:2021-07 Issue:7 Volume:19 Page:1480-1488.e14
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Meyersohn Nandini M.^ORCID,Mayrhofer Thomas,Corey Kathleen E.,Bittner Daniel O.,Staziaki Pedro V.^ORCID,Szilveszter Balint,Hallett Travis^ORCID,Lu Michael T.^ORCID,Puchner Stefan B.,Simon Tracey G.,Foldyna Borek,Voora Deepak^ORCID,Ginsburg Geoffrey S.,Douglas Pamela S.,Hoffmann Udo,Ferencik Maros

Funder

American Heart Association

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference47 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

3. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

4. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

5. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association;Pagano;Hepatology,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up;Hepatology Research;2024-08-19

2. Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial;American Journal of Preventive Cardiology;2024-06

3. MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials;Journal of Internal Medicine;2024-05-13

4. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

5. Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and MACCEs in Patients with Diabetic Foot Ulcers: An Ambispective Longitudinal Cohort Study;Diabetes, Metabolic Syndrome and Obesity;2024-03